HC
ABBV icon

HNP Capital’s AbbVie ABBV Stock Holding History

HNP Capital’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		$331K Sell
2,078
-85
-4% -$13K 0.09% 115
2022
Q4 		$350K Hold
2,163
– – 0.1% 111
2022
Q3 		$290K Sell
2,163
-140
-6% -$20.1K 0.08% 114
2022
Q2 		$353K Hold
2,303
– – 0.1% 118
2022
Q1 		$373K Sell
2,303
-75
-3% -$10.9K 0.09% 124
2021
Q4 		$322K Buy
2,378
+100
+4% +$11.8K 0.07% 138
2021
Q3 		$246K Sell
2,278
-100
-4% -$11.4K 0.06% 142
2021
Q2 		$268K Hold
2,378
– – 0.07% 133
2021
Q1 		$257K Sell
2,378
-134
-5% -$14.3K 0.08% 129
2020
Q4 		$269K Sell
2,512
-125
-5% -$12K 0.09% 116
2020
Q3 		$245K Buy
2,637
+71
+3% +$6.68K 0.09% 115
2020
Q2 		$254K Sell
2,566
-16,515
-87% -$1.45M 0.11% 107
2020
Q1 		$1.53M Buy
19,081
+16,082
+536% +$1.37M 0.23% 86
2019
Q4 		$267K Buy
+2,999
New +$249K 0.11% 100
2019
Q2 		– Sell
-2,594
Closed -$209K – 108
2019
Q1 		$209K Sell
2,594
-200
-7% -$16.4K 0.13% 101
2018
Q4 		$258K Buy
+2,794
New +$246K 0.17% 97

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

HNP Capital's ABBV Position: Q1 2023 in Review

HNP Capital reduced its AbbVie (ABBV) stake by 3.9% in Q1 2023, selling an estimated $13K and leaving 2,078 shares worth $331K. The position accounts for 0.09% of the portfolio, ranked #115.

HNP Capital first reported a position in ABBV in Q4 2018 and has held it in 16 quarters since. The position peaked at $1.53M in Q1 2020. 3,138 funds tracked by Wall St. Rank hold ABBV as of Q1 2023.

  • HNP Capital held 2,078 shares of AbbVie worth $331K as of Q1 2023.
  • HNP Capital sold 85 AbbVie shares in Q1 2023, an estimated $13K.
  • AbbVie made up 0.09% of HNP Capital's portfolio in Q1 2023, its #115 holding.
  • HNP Capital first reported a position in AbbVie in Q4 2018 and has held it in 16 quarters since.
  • HNP Capital's AbbVie position peaked at $1.53M in Q1 2020.
  • 3,138 funds tracked by Wall St. Rank held AbbVie as of Q1 2023.

Based on HNP Capital's 13F filing for Q1 2023, filed 18 May 2023.